Virtual screening of HER2-targeting drugs
2016
Alagappa University, Karaikudi, India
Using delphinidin as a query parent, this study is based on searching for homologous compounds that have safer pharmacological profiles for HER2 targeting in human breast cancer. After a screening of PubChem database and further validation procedures, a compound was identified with a higher affinity than delphinidin and a better ADMET profile. This study can serve as a starting point for the "in vitro" assessment of this identified HER2-targeting drug.
Virtual screening approaches in identification of bioactive compounds akin to delphinidin as potential HER2 inhibitors for the treatment of breast cancer
Sanjeev Kumar Singh
Added on: 07-30-2021
[1] http://journal.waocp.org/?sid=Entrez:PubMed&id=pmid:27221932&key=2016.17.4.2291[2] https://data.jrc.ec.europa.eu/dataset/ffebe454-ed9a-47cf-8a33-8cf70c1b7d38